Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-31

Clinical Trial Update: Study Assessing Safety & Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated the safety and effectiveness of a taurolidine-citrate catheter lock solution to prevent bloodstream infections in dialysis patients; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Taurolidine-citrate catheter lock solution (taurolidine-citrate catheter lock solution)

Snippet

Sponsor: CorMedix | Conditions: Kidney Failure, Chronic, Catheter-Related Infections | Phase 3 | Status: COMPLETED | Results posted: 2021-08-31